| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Thomas Spitznagel | Sr VP Technical Ops | 2026-02-15 | 5,520 | $1.71 | $9.44kSell |
| Ezio Bonvini | Sr VP Research CSO | 2026-02-15 | 6,433 | $1.71 | $11.00kSell |
| James Karrels | SVP and CFO | 2026-02-15 | 5,790 | $1.71 | $9.90kSell |
| Jeffrey Stuart Peters | Senior VP GC and Secretary | 2026-02-15 | 5,147 | $1.71 | $8.80kSell |
| Eric Blasius Risser | President and CEO | 2026-02-15 | 6,433 | $1.71 | $11.00kSell |
| Beth Ann Smith | VP Controller Treasurer | 2026-02-15 | 423 | $1.71 | $723.33Sell |
| James Karrels | SVP and CFO | 2026-02-08 | 3,860 | $1.81 | $6.99kSell |
| Jeffrey Stuart Peters | Senior VP GC and Secretary | 2026-02-08 | 3,474 | $1.81 | $6.29kSell |
| Eric Blasius Risser | President and CEO | 2026-02-08 | 4,311 | $1.81 | $7.80kSell |
| Thomas Spitznagel | Sr VP Technical Ops | 2026-02-08 | 3,186 | $1.81 | $5.77kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Target N. V. Biotech | 15.62% | 9,929,963 | $29.09M | Insider |
| Armistice Capital LLC | 9.95% | 6,324,000 | $18.53M | Institution |
| Vanguard Group Inc | 6.65% | 4,226,941 | $12.38M | Institution |
| Renaissance Technologies LLC | 4.58% | 2,908,631 | $8.52M | Institution |
| Acadian Asset Management LLC | 3.96% | 2,518,410 | $7.38M | Institution |
| Tpg Group Holdings Sbs Advisors Inc | 3.48% | 2,208,762 | $6.47M | Insider |
| Scott Koenig | 3.41% | 2,165,915 | $6.35M | Insider |
| Alta Biopharma Partners III LP | 3.17% | 2,013,509 | $5.90M | Insider |
| Millennium Management LLC | 3.11% | 1,974,480 | $5.79M | Institution |
| Interwest Partners VIII LP | 3.00% | 1,908,716 | $5.59M | Insider |